Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
“ Bendrofluazide treatment decreases the serum potassium concentration, reduces the initial insulin release and the glucose disposal , and, in addition, impairs insulin sensitivity.”